Tivdak (Tisotumab Vedotin-tftv)
- Medicine Name: Tivdak
- Generic Name: Tisotumab vedotin-tftv
- Dosage Form & Strength: Injection: 40mg
- Manufactured By: Seagen Inc.
Medical Uses
Tivdak is a tissue factor-directed antibody and microtubule inhibitor conjugate used to treat adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.
Recommended Dosage: The recommended dose is 2 mg per kg (up to a maximum of 200 mg for patients ≥100 kg) administered as an intravenous infusion over 30 minutes every 3 weeks until disease progression or unacceptable toxicity. This medicine is for intravenous infusion only. Do not administer tivdak injection as an intravenous push or bolus. Avoid mixing with, or administering as an infusion with, other medicinal products.
Warning & Precautions
- Ocular adverse reactions emerged in patients with cervical cancer treated with Tisotumab vedotin-tftv across clinical trials. Refer patients to an eye care specialist for an ophthalmic exam including visual acuity and slit lamp exam, before each dose.
- Peripheral neuropathy occurred in patients with cervical cancer treated with tisotumab vedotin 40 mg. Assess patients for signs/symptoms of neuropathy, such as paresthesia, tingling or a burning sensation, muscle weakness, neuropathic pain, or dysesthesia.
- Hemorrhage occurred in patients with cervical cancer treated with tisotumab vedotin. Monitor patients for signs/symptoms of hemorrhage. For patients experiencing pulmonary or CNS hemorrhage, permanently discontinue therapy.
- Life-threatening, severe or fatal pneumonitis can emerge in patients treated with ADC containing vedotin including tivdak 40 mg injection. Monitor patients for pulmonary signs/symptoms indicative of pneumonitis. Symptoms may include dyspnea, hypoxia, cough, or interstitial infiltrates on radiologic exams.
- Depending on the mechanism of action and findings, Tivdak can be responsible for causing fetal harm if administered to a pregnant woman. Females of reproductive age should use effective contraception during therapy and for 2 months after the final dose.
Documentation & Availability
What documents are required to import TIVDAK to India?
TIVDAK (tisotumab vedotin tftv) injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation are needed to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is TIVDAK available in India?
TIVDAK (tisotumab vedotin injection) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). S S Healthcare is facilitator providing input
- On availability of tivdak injection in India (Delhi, Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
TIVDAK can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of TIVDAK (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Toll-Free No: +91-7575883015 or write us at sshealthcare1012@gmail.com for tivdak 40 mg price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the TIVDAK (Cancer Treatment Medicines) from across the globe, and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Tivdak®?
Tisotumab vedotin-tftv is Generic Name for the trade name drug Tivdak®.
What is the Manufacturer Name of Tivdak®?
Tivdak® is manufactured by Seagen Inc.
Is Tivdak® approved by the FDA?
Yes, Tivdak® is approved by the FDA. Date of approval: September 20, 2021.
What is Tivdak®?
Tivdak is a chemotherapy medication and monoclonal antibody, aimed to treat adult patients with cervical cancer.
What is the dosage and form of Tivdak® supplied?
Tivdak® is supplied as For Injection: 40 mg as a lyophilized cake or powder in a single-dose vial for reconstitution for intravenous administration.
How much does Tisotumab cost in India?
The cost of tisotumab in India is reasonable. To procure this tisotumab vedotin cervical cancer medication authentically, you can call or WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the most common side effects due to Tivdak®?
Most common side effects due to Tivdak® include: rash, diarrhea, dry eye, tiredness, hair loss, nosebleed, changes in kidney function blood tests, nausea, and decreased red blood cell and white blood cell counts.
What are the storage conditions of Tivdak®?
Store the vials of Tivdak at 2°C to 8°C (36°F to 46°F) in the original carton in order to protect from light. Neither freeze nor shake it.
Is it safe to buy Tivdak® online?
Yes, In order to buy Tivdak (tisotumab vedotin-tftv) online, always look for a legitimate, WHO-GDP & ISO certified pharmaceutical wholesaler/distributor/supplier.
What are the Highlights of prescribing information for Tivdak®?
Click Here to download full Tivdak prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
